SLC1A2 and autism: This study highlighted the multi-faceted impact of GABA supplementation, and combination therapy (GABA, probiotics, VD3, and EAAT2 activator, β-lactam) on neurotransmitter balance, oxidative stress and social behavior in PPA-induced rodent model of autism.